Skip to main content
. Author manuscript; available in PMC: 2016 May 2.
Published in final edited form as: J Clin Investig Dermatol. 2015 Dec 15;3(2):10.13188/2373-1044.1000019. doi: 10.13188/2373-1044.1000019

Table 3.

Treatment of seborrheic dermatitis and dandruff.

Medication Dose/
Formulation
Regimen Mechanisms Side Effects References
TOPICAL Antifungals Ketoconazole 2% Shampoo, cream, gel or foam Scalp or skin: Twice/week × 4 weeks, then once/week for maintenance. Inhibition of fungal cell wall synthesis. ICD in <1% of patients. Itching, burning sensation and dryness in 3% of patients. [2,8,26,97101]
Bifonazole 1% shampoo, cream or ointment Scalp: every other day or once daily.
Skin: once daily.
ICD in 10% of patients. [8,26,99,102]
Miconazole Cream Skin: 1–2 times daily. ICD, itching, burning sensation. [47,97,103]
Ciclopirox Olamine 1.5% shampoo, cream, gel or lotion Scalp: 2–3 times/week × 4 weeks, then once/week for maintenance.
Skin: twice daily.
Inhibition of metal-dependent enzymes. ICD in <1% of patients. Itching, burning sensation in 2% of patients. [8,47,97,99,104,105]
Selenium sulfide 2.5% shampoo Scalp: Twice/week × 2 weeks, then once/week × 2 weeks. Repeat after 4–6 weeks. Cytostatic and keratolytic. ICD in ~3% of patients. Orange-brown scalp discoloration. [8,97,106,107]
Zinc Pyrithione 1% shampoo Scalp: 2–3 times/week. Increased cellular copper interferes with iron-sulfur proteins. ICD in ~3% of patients. [8,97,99,101,108,109]
Cortico-steroids Hydrocortisone 1% cream Skin: 1–2 times daily. Anti-inflammatory, anti-irritant. Risk of skin atrophy, telangiectasias, folliculitis, hypertrichosis, and hypopigmentation with prolonged use. [8,9,97,99,103,108]
Betamethasone dipropionate 0.05% lotion Scalp and skin: 1–2 times daily. [8,47,110]
Desonide 0.05% lotion, gel Scalp and skin: 2 times daily. [8,111113]
Fluocinolone 0.01% shampoo, lotion or cream Scalp or skin: Once or twice daily. [7,114]
Immuno-modulators Pimecrolimus 1% cream Skin: 1–2 times daily. Inhibition of cytokine production by T-lymphocyte. Risk of skin malignancy and lymphoma with prolonged use. [47,98,115118]
Tacrolimus 0.1% ointment Skin: 1–2 times daily × 4 weeks, then twice/week for maintenance. [26,97,109,118120]
Miscellaneous Coal tar 4% shampoo Scalp: 1–2 times/week. Antifungal, anti-inflammatory, keratolytic, reduces sebum production. Local folliculitis, ICD on fingers, psoriasis aggravation, skin atrophy, telangiectasias, hyper-pigmentation. Risk of squamous cell carcinoma with prolonged use. [4,8,47,117,121]
Lithium gluconate/succinate 8% ointment or gel Skin: twice daily × 8 weeks. Anti-inflammatory via increased IL-10 and decreased TLR2 and TLR4 in keratinocytes. ICD in <10% of patients. [8,122124]
Metronidazole 0.75% gel Skin: twice daily × 4 weeks. Anti-inflammatory via inhibition of free radical species. Rare contact sensitization with prolonged use. [5,47,125,126]
Phototherapy UVB: Cumulative dose of 9.8 J/cm2 Three time/week × 8 weeks or until clearing. Immuno-modulation and inhibition of cell proliferation. Burning, itching sensation during/after therapy. Risk of genital tumor with prolonged use. [26,127129]
SYSTEMIC Itraconazole Oral: 200 mg Once daily × 7 days, then once daily × 2 days/month for maintenance. Inhibition of fungal cell wall synthesis. Anti-inflammatory via inhibition of 5-lipoxygenase metabolites. Rare liver toxicity. [97,130,131]
Terbinafine Oral: 250 mg Once daily × 4–6 weeks or 12 days monthly × 3 months. Inhibition of cell membrane and cell wall synthesis. Rare tachycardia and insomnia. [132134]

Note: Shampoos, foams and lotions are better suited for treating seborrheic dermatitis and dandruff on the scalp; gels, creams and ointments are used to treat seborrheic dermatitis on body locations other than the scalp.

ICD: Irritant Contact Dermatitis.